Paris, France

Didier Carcano

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Didier Carcano

Introduction

Didier Carcano is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of metabolic health. With a total of 2 patents, Carcano's work focuses on the use of lactic acid bacteria for therapeutic purposes.

Latest Patents

Carcano's latest patents include innovative methods for treating endotoxemia. The first patent involves the use of a bacterium selected from a lactic acid bacterium, or a mixture thereof, for treating metabolic endotoxemia. This invention aims to inhibit bacterial translocation and regulate lipid absorption in mammals. The second patent also focuses on lactic acid bacteria and bifidobacteria for treating endotoxemia, emphasizing similar therapeutic applications.

Career Highlights

Throughout his career, Didier Carcano has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Dupont Nutrition Biosciences Aps and Danisco A/S. His work in these organizations has contributed to advancements in nutritional science and health.

Collaborations

Carcano has collaborated with esteemed colleagues in his field, including Pierre Desreumaux and Sampo Lahtinen. These partnerships have fostered innovation and research in the applications of lactic acid bacteria.

Conclusion

Didier Carcano's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact the understanding and treatment of metabolic health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…